- Report
- July 2024
- 133 Pages
Russia
From €2862EUR$2,999USD£2,398GBP
- Report
- July 2024
- 131 Pages
China
From €2862EUR$2,999USD£2,398GBP
- Report
- July 2024
- 138 Pages
Japan
From €2862EUR$2,999USD£2,398GBP
- Report
- July 2024
- 124 Pages
Saudi Arabia
From €2862EUR$2,999USD£2,398GBP
- Report
- July 2024
- 136 Pages
Turkey
From €2862EUR$2,999USD£2,398GBP
- Report
- July 2024
- 128 Pages
Canada
From €2862EUR$2,999USD£2,398GBP
- Report
- July 2024
- 140 Pages
France
From €2862EUR$2,999USD£2,398GBP
- Report
- July 2024
- 138 Pages
Brazil
From €2862EUR$2,999USD£2,398GBP
- Report
- July 2024
- 128 Pages
Italy
From €2862EUR$2,999USD£2,398GBP
- Report
- July 2024
- 133 Pages
Spain
From €2862EUR$2,999USD£2,398GBP
- Report
- May 2023
- 132 Pages
India
From €2862EUR$2,999USD£2,398GBP
- Report
- February 2024
- 125 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Report
- February 2025
- 85 Pages
India
From €3340EUR$3,500USD£2,799GBP
- Report
- December 2024
- 85 Pages
India
From €3340EUR$3,500USD£2,799GBP
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2022
- 177 Pages
From €3293EUR$3,450USD£2,759GBP
- Report
- October 2022
- 174 Pages
North America
From €3293EUR$3,450USD£2,759GBP
- Report
- October 2022
- 181 Pages
Middle East, Africa
From €3293EUR$3,450USD£2,759GBP
- Report
- October 2022
- 202 Pages
Europe
From €3293EUR$3,450USD£2,759GBP
- Report
- October 2022
- 205 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more